Operating Income (Loss) of WINDTREE THERAPEUTICS INC /DE/ from 30 Jun 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
WINDTREE THERAPEUTICS INC /DE/ quarterly and annual Operating Income (Loss) in USD history and change rate from 30 Jun 2010 to 30 Sep 2025.
  • WINDTREE THERAPEUTICS INC /DE/ Operating Income (Loss) for the quarter ending 30 Sep 2025 was $19,882,000, a 319% decline year-over-year.
  • WINDTREE THERAPEUTICS INC /DE/ Operating Income (Loss) for the twelve months ending 30 Sep 2025 was $33,497,000, a 31% decline year-over-year.
  • WINDTREE THERAPEUTICS INC /DE/ annual Operating Income (Loss) for 2024 was $26,139,000, a 27% decline from 2023.
  • WINDTREE THERAPEUTICS INC /DE/ annual Operating Income (Loss) for 2023 was $20,597,000, a 50% increase from 2022.
  • WINDTREE THERAPEUTICS INC /DE/ annual Operating Income (Loss) for 2022 was $41,333,000, a 47% increase from 2021.
Source SEC data
View on sec.gov
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

WINDTREE THERAPEUTICS INC /DE/ Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $33,497,000 $19,882,000 -$15,141,000 -319% 01 Jul 2025 30 Sep 2025 10-Q 19 Nov 2025 2025 Q3
Q2 2025 $18,356,000 $3,984,000 +$7,468,000 +65% 01 Apr 2025 30 Jun 2025 10-Q 19 Aug 2025 2025 Q2
Q1 2025 $25,824,000 $4,090,000 +$315,000 +7.2% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $26,139,000 $5,541,000 -$582,000 -12% 01 Oct 2024 31 Dec 2024 10-K 15 Apr 2025 2024 FY
Q3 2024 $25,557,000 $4,741,000 -$51,000 -1.1% 01 Jul 2024 30 Sep 2024 10-Q 19 Nov 2025 2025 Q3
Q2 2024 $25,506,000 $11,452,000 -$4,695,000 -69% 01 Apr 2024 30 Jun 2024 10-Q 19 Aug 2025 2025 Q2
Q1 2024 $20,811,000 $4,405,000 -$214,000 -5.1% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q4 2023 $20,597,000 $4,959,000 +$5,853,000 +54% 01 Oct 2023 31 Dec 2023 10-K 15 Apr 2025 2024 FY
Q3 2023 $26,450,000 $4,690,000 -$40,000 -0.86% 01 Jul 2023 30 Sep 2023 10-Q 26 Nov 2024 2024 Q3
Q2 2023 $26,410,000 $6,757,000 +$10,781,000 +61% 01 Apr 2023 30 Jun 2023 10-Q 19 Aug 2024 2024 Q2
Q1 2023 $37,191,000 $4,191,000 +$4,142,000 +50% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
Q4 2022 $41,333,000 $10,812,000 +$3,880,000 +26% 01 Oct 2022 31 Dec 2022 10-K 16 Apr 2024 2023 FY
Q3 2022 $45,213,000 $4,650,000 +$3,497,000 +43% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $48,710,000 $17,538,000 +$27,824,000 +61% 01 Apr 2022 30 Jun 2022 10-Q 07 Aug 2023 2023 Q2
Q1 2022 $76,534,000 $8,333,000 +$746,000 +8.2% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q4 2021 $77,280,000 $14,692,000 -$7,731,000 -111% 01 Oct 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 $69,549,000 $8,147,000 +$558,000 +6.4% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $70,107,000 $45,362,000 -$37,414,000 -471% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022 2022 Q2
Q1 2021 $32,693,000 $9,079,000 -$2,376,000 -35% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q4 2020 $30,317,000 $6,961,000 -$2,407,000 -53% 01 Oct 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q3 2020 $27,910,000 $8,705,000 -$1,518,000 -21% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2021 Q3
Q2 2020 $26,392,000 $7,948,000 -$1,453,000 -22% 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021 2021 Q2
Q1 2020 $24,939,000 $6,703,000 -$46,000 -0.69% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q4 2019 $24,893,000 $4,554,000 +$297,000 +6.1% 01 Oct 2019 31 Dec 2019 10-K 03 Apr 2020 2019 FY
Q3 2019 $25,190,000 $7,187,000 -$3,719,000 -107% 01 Jul 2019 30 Sep 2019 10-Q 16 Nov 2020 2020 Q3
Q2 2019 $21,471,000 $6,495,000 -$3,459,000 -114% 01 Apr 2019 30 Jun 2019 10-Q 14 Aug 2020 2020 Q2
Q1 2019 $18,012,000 $6,657,000 -$1,817,000 -38% 01 Jan 2019 31 Mar 2019 10-Q 13 May 2020 2020 Q1
Q4 2018 $16,195,000 $4,851,000 -$1,353,000 -39% 01 Oct 2018 31 Dec 2018 10-K 03 Apr 2020 2019 FY
Q3 2018 $14,842,000 $3,468,000 +$1,326,000 +28% 01 Jul 2018 30 Sep 2018 10-K 03 Apr 2020 2019 FY
Q2 2018 $16,168,000 $3,036,000 +$3,104,000 +51% 01 Apr 2018 30 Jun 2018 10-K 03 Apr 2020 2019 FY
Q1 2018 $19,272,000 $4,840,000 +$3,276,000 +40% 01 Jan 2018 31 Mar 2018 10-K 03 Apr 2020 2019 FY
Q4 2017 $22,548,000 $3,498,000 +$2,870,000 +45% 01 Oct 2017 31 Dec 2017 10-K/A 23 Apr 2019 2018 FY
Q3 2017 $25,418,000 $4,794,000 +$2,939,000 +38% 01 Jul 2017 30 Sep 2017 10-K/A 23 Apr 2019 2018 FY
Q2 2017 $28,357,000 $6,140,000 +$3,853,000 +39% 01 Apr 2017 30 Jun 2017 10-K/A 23 Apr 2019 2018 FY
Q1 2017 $32,210,000 $8,116,000 +$5,826,000 +42% 01 Jan 2017 31 Mar 2017 10-K/A 23 Apr 2019 2018 FY
Q4 2016 $38,036,000 $6,368,000 +$3,413,000 +35% 01 Oct 2016 31 Dec 2016 10-K 17 Apr 2018 2017 FY
Q3 2016 $41,449,000 $7,733,000 +$710,000 +8.4% 01 Jul 2016 30 Sep 2016 10-K 17 Apr 2018 2017 FY
Q2 2016 $42,159,000 $9,993,000 +$444,000 +4.3% 01 Apr 2016 30 Jun 2016 10-K 17 Apr 2018 2017 FY
Q1 2016 $42,603,000 $13,942,000 -$2,769,000 -25% 01 Jan 2016 31 Mar 2016 10-K 17 Apr 2018 2017 FY
Q4 2015 $39,834,000 $9,781,000 +$1,445,000 +13% 01 Oct 2015 31 Dec 2015 10-K 31 Mar 2017 2016 FY
Q3 2015 $41,279,000 $8,443,000 +$1,884,000 +18% 01 Jul 2015 30 Sep 2015 10-K 31 Mar 2017 2016 FY
Q2 2015 $43,163,000 $10,437,000 +$505,000 +4.6% 01 Apr 2015 30 Jun 2015 10-K 31 Mar 2017 2016 FY
Q1 2015 $43,668,000 $11,173,000 -$410,000 -3.8% 01 Jan 2015 31 Mar 2015 10-K 31 Mar 2017 2016 FY
Q4 2014 $43,258,000 $11,226,000 -$961,000 -9.4% 01 Oct 2014 31 Dec 2014 10-K 29 Mar 2016 2015 FY
Q3 2014 $42,297,000 $10,327,000 +$486,000 +4.5% 01 Jul 2014 30 Sep 2014 10-K 29 Mar 2016 2015 FY
Q2 2014 $42,783,000 $10,942,000 -$132,000 -1.2% 01 Apr 2014 30 Jun 2014 10-K 29 Mar 2016 2015 FY
Q1 2014 $42,651,000 $10,763,000 +$1,857,000 +15% 01 Jan 2014 31 Mar 2014 10-K 29 Mar 2016 2015 FY
Q4 2013 $44,508,000 $10,265,000 +$2,160,000 +17% 01 Oct 2013 31 Dec 2013 10-K 16 Mar 2015 2014 FY
Q3 2013 $46,668,000 $10,813,000 -$815,000 -8.2% 01 Jul 2013 30 Sep 2013 10-K 16 Mar 2015 2014 FY
Q2 2013 $45,853,000 $10,810,000 -$1,994,000 -23% 01 Apr 2013 30 Jun 2013 10-K 16 Mar 2015 2014 FY
Q1 2013 $43,859,000 $12,620,000 -$6,040,000 -92% 01 Jan 2013 31 Mar 2013 10-K 16 Mar 2015 2014 FY
Q4 2012 $37,819,000 $12,425,000 -$6,522,000 -110% 01 Oct 2012 31 Dec 2012 10-K 17 Mar 2014 2013 FY
Q3 2012 $31,297,000 $9,998,000 -$3,828,000 -62% 01 Jul 2012 30 Sep 2012 10-K 17 Mar 2014 2013 FY
Q2 2012 $27,469,000 $8,816,000 -$2,436,000 -38% 01 Apr 2012 30 Jun 2012 10-K 17 Mar 2014 2013 FY
Q1 2012 $25,033,000 $6,580,000 -$521,000 -8.6% 01 Jan 2012 31 Mar 2012 10-K 17 Mar 2014 2013 FY
Q4 2011 $24,512,000 $5,903,000 01 Oct 2011 31 Dec 2011 10-K 15 Mar 2013 2012 FY
Q3 2011 $6,170,000 +$33,000 +0.53% 01 Jul 2011 30 Sep 2011 10-K 15 Mar 2013 2012 FY
Q2 2011 $6,380,000 -$152,000 -2.4% 01 Apr 2011 30 Jun 2011 10-K 15 Mar 2013 2012 FY
Q1 2011 $6,059,000 01 Jan 2011 31 Mar 2011 10-K 15 Mar 2013 2012 FY
Q3 2010 $6,203,000 01 Jul 2010 30 Sep 2010 10-Q 14 Nov 2011 2011 Q3
Q2 2010 $6,228,000 01 Apr 2010 30 Jun 2010 10-Q 15 Aug 2011 2011 Q2

WINDTREE THERAPEUTICS INC /DE/ Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $26,139,000 -$5,542,000 -27% 01 Jan 2024 31 Dec 2024 10-K 15 Apr 2025 2024 FY
2023 $20,597,000 +$20,736,000 +50% 01 Jan 2023 31 Dec 2023 10-K 15 Apr 2025 2024 FY
2022 $41,333,000 +$35,947,000 +47% 01 Jan 2022 31 Dec 2022 10-K 16 Apr 2024 2023 FY
2021 $77,280,000 -$46,963,000 -155% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
2020 $30,317,000 -$5,424,000 -22% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
2019 $24,893,000 -$8,698,000 -54% 01 Jan 2019 31 Dec 2019 10-K 29 Mar 2021 2020 FY
2018 $16,195,000 +$6,353,000 +28% 01 Jan 2018 31 Dec 2018 10-K 03 Apr 2020 2019 FY
2017 $22,548,000 +$15,488,000 +41% 01 Jan 2017 31 Dec 2017 10-K/A 23 Apr 2019 2018 FY
2016 $38,036,000 +$1,798,000 +4.5% 01 Jan 2016 31 Dec 2016 10-K 17 Apr 2018 2017 FY
2015 $39,834,000 +$3,424,000 +7.9% 01 Jan 2015 31 Dec 2015 10-K 31 Mar 2017 2016 FY
2014 $43,258,000 +$1,250,000 +2.8% 01 Jan 2014 31 Dec 2014 10-K 29 Mar 2016 2015 FY
2013 $44,508,000 -$6,689,000 -18% 01 Jan 2013 31 Dec 2013 10-K 16 Mar 2015 2014 FY
2012 $37,819,000 -$13,307,000 -54% 01 Jan 2012 31 Dec 2012 10-K 16 Mar 2015 2014 FY
2011 $24,512,000 +$1,016,000 +4% 01 Jan 2011 31 Dec 2011 10-K 17 Mar 2014 2013 FY
2010 $25,528,000 01 Jan 2010 31 Dec 2010 10-K 15 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.